Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul 24;104(30):12451-6.
doi: 10.1073/pnas.0703451104. Epub 2007 Jul 17.

Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator

Affiliations

Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator

Aniko Hever et al. Proc Natl Acad Sci U S A. .

Abstract

Endometriosis affects 10-20% of women of reproductive age and is associated with pelvic pain and infertility, and its pathogenesis is not well understood. We used genomewide transcriptional profiling to characterize endometriosis and found that it exhibits a gene expression signature consistent with an underlying autoimmune mechanism. Endometriosis lesions are characterized by the presence of abundant plasma cells, many of which produce IgM, and macrophages that produce BLyS/BAFF/TNFSF13B, a member of the TNF superfamily implicated in other autoimmune diseases. B lymphocyte stimulator (BLyS) protein was found elevated in the serum of endometriosis patients. These observations suggest a model for the pathology of endometriosis where BLyS-responsive plasma cells interact with retrograde menstrual tissues to give rise to endometriosis lesions.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: A.H., R.B.R., P.H., D.G., E.W., P.J.C., R.A.M., and A.Z. were employed by Neurocrine Biosciences and owned common stock of this company at the time this study was performed.

Figures

Fig. 1.
Fig. 1.
IPA was used to identify pathways altered in endometriosis compared with normal endometrium, and the two most significant networks associated with immune responses are shown (merged). The significance values of each were Network 1, P = 10−38, and Network 2, P = 10−26. For explanation of significance values, see Materials and Methods.
Fig. 2.
Fig. 2.
Endometriosis lesions contain macrophages and plasma cells. (a) Staining with H&E showing plasma cells in endometriosis lesions (arrows). (Magnification: ×10.) (b) Immunohistochemical analysis shows that some of the plasma cells express IgM (arrows). (Magnification: ×40.) (c) H&E staining revealed many macrophages with hemosiderin in the lesions of ovarian endometriosis. (Magnification: ×10.) (d) Staining with anti-CD68 confirmed the presence of macrophages in these lesions. (Magnification: ×40.)
Fig. 3.
Fig. 3.
BLyS and its receptor BCMA are significantly altered in endometriosis. (a) Qualitative RT-PCR (TaqMan) confirmed the overexpression of BLyS mRNA in endometriosis vs. control endometrium, as originally identified through microarray analysis. Relative expression values are expressed as mean of 2(40−Ct) ± SEM: endometrium, 100 ± 15 (n = 16); endometriosis, 886 ± 263 (n = 13). (b) BCMA mRNA was also found to be overexpressed in endometriosis vs. control endometrium by quantitative RT-PCR (TaqMan). Relative expression values are expressed as mean of 2(40−Ct) ± SEM: endometrium, 43 ± 13 (n = 16); endometriosis, 290 ± 89 (n = 13). (c) Immunohistochemical staining revealed that BlyS is produced by macrophages in endometriotic lesions. (Magnification: ×100.) (d) Individual serum BlyS protein levels in 21 healthy control females and 31 patients with endometriosis were measured by ELISA. The data show the mean pg/ml values of each group ± SEM: control, 523 ± 74; endometriosis, 1,695 ± 188.

References

    1. Lebovic DI, Mueller MD, Taylor RN. Fertil Steril. 2001;75:1–10. - PubMed
    1. Giudice LC, Kao LC. Lancet. 2004;364:1789–1799. - PubMed
    1. Berkley KJ, Rapkin AJ, Papka RE. Science. 2005;308:1587–1589. - PubMed
    1. Brosens I, Puttemans P, Campo R, Gordts S, Brosens J. Curr Opin Obstet Gynecol. 2003;15:519–522. - PubMed
    1. Valle RF, Sciarra JJ. Ann NY Acad Sci. 2003;997:229–239. - PubMed

MeSH terms

Substances